Prot# CZOL446E2352: A Prospective, Randomized, Dbl-Blind, Stratified, Placebo-Controlled, Multi-Center, 3-Arm Trial of the Continued Efficacy & Safety of Zometa(Every 4 Wks v Every 12 Wks v Placebo)in Ptnts w/Documented Bone Metastases from Bre

Project: Research project

Project Details

StatusFinished
Effective start/end date1/29/079/1/11

Funding

  • Novartis Pharmaceuticals Corporation (CZOL446E2352)